Cargando…
Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
The term “interstitial pneumonia with autoimmune features” (IPAF) has been recently proposed. We here investigate the clinical characteristics of IPAF and evaluate the clinical implications of CXCL1-CXCR2 axis in IPAF. An increased plasma level of CXCL1 was exhibited in IPAF compared to idiopathic i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154180/ https://www.ncbi.nlm.nih.gov/pubmed/27958346 http://dx.doi.org/10.1038/srep38949 |
_version_ | 1782474834809192448 |
---|---|
author | Liang, Minrui Jiang, Zhixing Huang, Qiong Liu, Lei Xue, Yu Zhu, Xiaoxia Yu, Yiyun Wan, Weiguo Yang, Haihua Zou, Hejian |
author_facet | Liang, Minrui Jiang, Zhixing Huang, Qiong Liu, Lei Xue, Yu Zhu, Xiaoxia Yu, Yiyun Wan, Weiguo Yang, Haihua Zou, Hejian |
author_sort | Liang, Minrui |
collection | PubMed |
description | The term “interstitial pneumonia with autoimmune features” (IPAF) has been recently proposed. We here investigate the clinical characteristics of IPAF and evaluate the clinical implications of CXCL1-CXCR2 axis in IPAF. An increased plasma level of CXCL1 was exhibited in IPAF compared to idiopathic interstitial pneumonia (IIP), chronic obstructive pulmonary disease (COPD), and healthy controls. Additionally, plasma CXCL1 levels were clinically associated with diffusing capacity of the lungs for carbon monoxide (DLCO), erythrocyte sedimentation rate (ESR), and involved parenchyma extension in IPAF. Furthermore, circulating CXCL1 levels were highest in IPAF patients with acute exacerbations. CXCR2, the chemokine receptor for CXCL1, was readily observed in inflammatory aggregates and endothelial cells in IPAF lungs, but was lower in IIP lungs and healthy lungs. Interestingly, increased CXCL1 concentrations in BALF paralleled neutrophil counts in IPAF. Overall, the plasma concentrations of CXCL1 indicated the disease activity and prognosis in IPAF. Thus, the CXCL1/CXCR2 axis appears to be involved in the progression of IPAF. |
format | Online Article Text |
id | pubmed-5154180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51541802016-12-28 Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF) Liang, Minrui Jiang, Zhixing Huang, Qiong Liu, Lei Xue, Yu Zhu, Xiaoxia Yu, Yiyun Wan, Weiguo Yang, Haihua Zou, Hejian Sci Rep Article The term “interstitial pneumonia with autoimmune features” (IPAF) has been recently proposed. We here investigate the clinical characteristics of IPAF and evaluate the clinical implications of CXCL1-CXCR2 axis in IPAF. An increased plasma level of CXCL1 was exhibited in IPAF compared to idiopathic interstitial pneumonia (IIP), chronic obstructive pulmonary disease (COPD), and healthy controls. Additionally, plasma CXCL1 levels were clinically associated with diffusing capacity of the lungs for carbon monoxide (DLCO), erythrocyte sedimentation rate (ESR), and involved parenchyma extension in IPAF. Furthermore, circulating CXCL1 levels were highest in IPAF patients with acute exacerbations. CXCR2, the chemokine receptor for CXCL1, was readily observed in inflammatory aggregates and endothelial cells in IPAF lungs, but was lower in IIP lungs and healthy lungs. Interestingly, increased CXCL1 concentrations in BALF paralleled neutrophil counts in IPAF. Overall, the plasma concentrations of CXCL1 indicated the disease activity and prognosis in IPAF. Thus, the CXCL1/CXCR2 axis appears to be involved in the progression of IPAF. Nature Publishing Group 2016-12-13 /pmc/articles/PMC5154180/ /pubmed/27958346 http://dx.doi.org/10.1038/srep38949 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Liang, Minrui Jiang, Zhixing Huang, Qiong Liu, Lei Xue, Yu Zhu, Xiaoxia Yu, Yiyun Wan, Weiguo Yang, Haihua Zou, Hejian Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF) |
title | Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF) |
title_full | Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF) |
title_fullStr | Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF) |
title_full_unstemmed | Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF) |
title_short | Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF) |
title_sort | clinical association of chemokine (c-x-c motif) ligand 1 (cxcl1) with interstitial pneumonia with autoimmune features (ipaf) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154180/ https://www.ncbi.nlm.nih.gov/pubmed/27958346 http://dx.doi.org/10.1038/srep38949 |
work_keys_str_mv | AT liangminrui clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT jiangzhixing clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT huangqiong clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT liulei clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT xueyu clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT zhuxiaoxia clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT yuyiyun clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT wanweiguo clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT yanghaihua clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf AT zouhejian clinicalassociationofchemokinecxcmotifligand1cxcl1withinterstitialpneumoniawithautoimmunefeaturesipaf |